Bridgeway Capital Management Inc. grew its position in Cutera, Inc. (NASDAQ:CUTR) by 25.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,400 shares of the medical device company’s stock after acquiring an additional 5,100 shares during the period. Bridgeway Capital Management Inc. owned 0.18% of Cutera worth $827,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the company. Piedmont Investment Advisors LLC acquired a new stake in shares of Cutera in the second quarter valued at approximately $128,000. SG Americas Securities LLC acquired a new stake in shares of Cutera in the second quarter valued at approximately $154,000. United Services Automobile Association acquired a new stake in shares of Cutera in the second quarter valued at approximately $208,000. Assenagon Asset Management S.A. acquired a new stake in shares of Cutera in the third quarter valued at approximately $263,000. Finally, Los Angeles Capital Management & Equity Research Inc. acquired a new stake in shares of Cutera in the second quarter valued at approximately $347,000.
CUTR opened at $18.13 on Friday. Cutera, Inc. has a 52 week low of $17.94 and a 52 week high of $56.05. The firm has a market cap of $263.89 million, a price-to-earnings ratio of 23.55 and a beta of 0.87.
Cutera (NASDAQ:CUTR) last released its earnings results on Tuesday, November 6th. The medical device company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.08. Cutera had a net margin of 11.16% and a negative return on equity of 0.50%. The firm had revenue of $40.60 million during the quarter, compared to analyst estimates of $40.03 million. During the same quarter in the previous year, the business earned $0.42 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. Equities analysts forecast that Cutera, Inc. will post -0.29 earnings per share for the current fiscal year.
A number of brokerages recently weighed in on CUTR. Zacks Investment Research raised shares of Cutera from a “strong sell” rating to a “hold” rating in a report on Wednesday. ValuEngine raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Thursday, November 1st. Sidoti set a $50.00 price target on shares of Cutera and gave the company a “buy” rating in a report on Friday, October 5th. Stephens lowered their price target on shares of Cutera from $40.00 to $24.94 and set a “sell” rating for the company in a report on Friday, October 5th. Finally, Stifel Nicolaus lowered their price target on shares of Cutera from $45.00 to $29.00 and set a “hold” rating for the company in a report on Friday, October 5th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $39.24.
TRADEMARK VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/12/08/cutera-inc-cutr-shares-bought-by-bridgeway-capital-management-inc.html.
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
See Also: What is the NASDAQ?
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.